Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1996
10/17/1996WO1996032385A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
10/17/1996WO1996032383A1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same
10/17/1996WO1996032382A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/17/1996WO1996032381A1 Carbazole derivative
10/17/1996WO1996032380A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
10/17/1996WO1996032376A1 Novel borneol esters, process for their preparation and their pharmaceutical use
10/17/1996WO1996032375A1 O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same
10/17/1996WO1996032130A1 The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
10/17/1996WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996WO1996032125A1 Methods for treating motor deficits
10/17/1996WO1996032120A1 Anionic oxygen radicals containing therapeutic agents and their use in pain relief
10/17/1996WO1996032113A1 Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods
10/17/1996WO1996032111A1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
10/17/1996WO1996032105A1 Lactacystin analogs
10/17/1996WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
10/17/1996DE19514524A1 Anellierte beta-Carboline Fused-beta-carbolines
10/17/1996DE19514048A1 Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern Trapidil for use in the treatment of immunomodulatory influenced diseases
10/17/1996DE19513990A1 Benzimidazol-Derivate Benzimidazole derivatives
10/17/1996CA2220827A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/17/1996CA2218033A1 Acetamide derivative, process for preparing the same, and a pharmaceutical composition containing the same
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2217877A1 Preparation of chiral 5-aminocarbonyl-5h-dibenzo-¬a,d|cyclohepten-5,10-imines by optical resolution
10/17/1996CA2217817A1 Lactacystin analogs
10/17/1996CA2217719A1 Anellated .beta.-carbolines
10/17/1996CA2216655A1 New borneol esters, process for their production, and their pharmaceutical use
10/16/1996EP0737685A1 Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
10/16/1996EP0737683A1 N-2-(Phthalimido)ethyl trans-piperidine-2,5-dicarboxylates as intermediates in the preparation of perhydro-1H-pyrido[1,2-a]pyrazines
10/16/1996EP0737678A1 4-Indolylpiperazinyl derivatives
10/16/1996EP0737677A1 4-Indolylpiperazinyl derivates
10/16/1996EP0737670A1 Tricyclic amides, processes for their preparation, and pharmaceutical compositions containing them
10/16/1996EP0737204A1 Cs-1 peptidomimetics, compositions and methods of using the same
10/16/1996EP0737200A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
10/16/1996EP0737199A1 Method for preparing concentrated biologically active silicon compounds
10/16/1996EP0737194A1 Diazabicyclic neurokinin antagonists
10/16/1996EP0737193A1 Pyrazolopyridine adenosine antagonists
10/16/1996EP0737192A1 Substituted morpholine derivatives and their use as therapeutic agents
10/16/1996EP0737189A1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders
10/16/1996EP0737187A1 Benzoxazine derivatives, methods for obtaining same and their use as drugs
10/16/1996EP0737074A1 Botulinum toxins for treating various disorders and associated pain
10/16/1996EP0737070A1 Vitamin d 3? analogues and pathway to mediate disorders
10/16/1996EP0670837B1 Method of preparing beta-carbolines
10/16/1996EP0526529B1 An improved process for the preparation of substituted indolone derivatives
10/16/1996CN1133593A Piperazine compounds used in therapy
10/16/1996CN1133563A Novel tripeptides useful in immune and CNS therapy
10/16/1996CN1133288A Compound with 1-(aryl Chain olefine)-4-(aryl methyl) piperazine structure, preparation process thereof and medicine thereof
10/16/1996CN1133287A Inhibitor for squalene synthetic enzyme
10/16/1996CN1133173A Preparation of diuretic by using neuropsychic tension antagonist
10/16/1996CN1033031C Modified prepn. of gangliosides and functional derivatives thereof
10/16/1996CN1033029C Prepn. of indenoindole compound
10/15/1996US5565580 Treatment of central nervous system disorders
10/15/1996US5565579 Neuroprotective agent
10/15/1996US5565568 Useful in treatment or prevention of a physiological disorder associated with an excess of tachykinins
10/15/1996US5565486 Administering culture product of the fungus acremonium strictum as an anticonvulsant, anxiolytic agent, muscle relaxant, hypnotic or memory enhancer
10/15/1996US5565483 3-substituted oxindole derivatives as potassium channel modulators
10/15/1996US5565475 Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
10/15/1996US5565474 1-heteroarylazetidines and -pyrrolidines process for their preparation and pharmaceutical compositions containing them
10/15/1996US5565466 Methods for modulating the human sexual response
10/15/1996US5565455 Method for treating substance abuse disorders
10/15/1996US5565453 Antipsychotic agent
10/15/1996US5565447 Almotriptan malate; treating headaches, movement disorders, depression, anxiety
10/15/1996US5565430 Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
10/15/1996US5565331 Nucleic acids encoding neural axon outgrowth modulators
10/11/1996CA2173693A1 4-indolylpiperazinyl derivatives
10/11/1996CA2173690A1 4-indolylpiperazinyl derivatives
10/10/1996WO1996031599A1 Ndf peptides
10/10/1996WO1996031511A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/10/1996WO1996031508A1 Biphenylamide derivatives as 5ht1d antagonists
10/10/1996WO1996031499A1 Novel heterocyclic compounds
10/10/1996WO1996031498A1 Novel heterocyclic compounds
10/10/1996WO1996031497A1 Novel heterocyclic compounds
10/10/1996WO1996031481A1 Novel heterocyclic compounds
10/10/1996WO1996031475A2 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
10/10/1996WO1996031474A1 Novel heterocyclic compounds
10/10/1996WO1996031471A1 Novel method
10/10/1996WO1996031468A1 Novel heterocyclic compounds
10/10/1996WO1996031462A1 Benzamides for neurodegenerative disorder treatment
10/10/1996WO1996031461A1 Phenoxyethylamine derivatives having high affinity for the 5-ht1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
10/10/1996WO1996031214A1 2-acylaminopropanamides as tachykinin receptor antagonists
10/10/1996WO1996031210A1 USE OF IMIDAZO[1,2-a]PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DISFUNCTION OF THE NEURAL CIRCUITS OF THE BASAL GANGLIA
10/10/1996WO1996031209A1 Pharmaceutical agents for the treatment of alzheimer's disease
10/10/1996WO1996031208A2 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
10/10/1996WO1996022990A3 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996WO1996012737A3 Compositions and treatment for multiple sclerosis
10/10/1996CA2217651A1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
10/10/1996CA2217461A1 2-acylaminopropanamides as tachykinin receptor antagonists
10/10/1996CA2217206A1 Novel heterocyclic compounds
10/10/1996CA2217202A1 Novel heterocyclic compounds
10/10/1996CA2217200A1 Novel method
10/10/1996CA2217198A1 Novel heterocyclic compounds
10/10/1996CA2217197A1 Novel heterocyclic compounds
10/10/1996CA2217194A1 Novel heterocyclic compounds
10/10/1996CA2217130A1 Novel heterocyclic compounds
10/10/1996CA2215469A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
10/10/1996CA2215166A1 Benzamides for neurodegenerative disorder treatment
10/09/1996EP0736534A1 Process for preparing epibatidine
10/09/1996EP0736531A1 Alpha-substituted pyridazino quinoline compounds
10/09/1996EP0736526A1 Pyrazolidine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
10/09/1996EP0736525A1 Benzonitriles and -fluorides as 5-HT agonists and antagonists
10/09/1996EP0736039A1 Compounds with growth hormone releasing properties
1 ... 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 ... 1833